Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 32,280 |
|
|||||
| News | - | ||||||
| Day High | 0.6785 | Low High |
|||||
| Day Low | 0.600101 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Alzamend Neuro Inc | ALZN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.016 | 2.47% | 0.665 | 09:32:14 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.645 | 0.600101 | 0.6785 | 0.6336 | 0.649 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 236 | 32,280 | US$ 0.643838 | US$ 20,783 | - | 0.4388 - 11.91 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:32:14 | formt | 100 | US$ 0.665 | USD |
Alzamend Neuro Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.63M | 7.12M | - | 0 | -14.88M | -2.09 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alzamend Neuro News
| Date | Time | Source | News Article |
|---|---|---|---|
| 17/5/2024 | 06:30 | Edgar (US Regulatory) | Form 5 - Annual statement of changes in beneficial ownership.. |
| 14/5/2024 | 22:00 | Business Wire | Alzamend Neuro Announces Initial Closing of Private.. |
| 14/5/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/5/2024 | 07:06 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 11/5/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 10/5/2024 | 20:30 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 10/5/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/5/2024 | 06:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 09/5/2024 | 22:00 | Business Wire | Alzamend Neuro Announces Agreement for Registered Direct.. |
| 08/5/2024 | 06:31 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 08/5/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07/5/2024 | 22:00 | Business Wire | Alzamend Neuro Announces Termination of At-the-Market Equity.. |
Historical ALZN Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.5723 | 0.73 | 0.4894 | 0.5906951 | 161,986 | 0.0927 | 16.20% |
| 1 Month | 0.714 | 0.78 | 0.4388 | 0.598943 | 103,691 | -0.049 | -6.86% |
| 3 Months | 0.90 | 1.29 | 0.4388 | 0.8470079 | 85,108 | -0.235 | -26.11% |
| 6 Months | 1.48 | 1.92 | 0.4388 | 1.08 | 110,799 | -0.815 | -55.07% |
| 1 Year | 7.80 | 11.91 | 0.4388 | 3.89 | 151,329 | -7.14 | -91.47% |
| 3 Years | 435.00 | 503.25 | 0.4388 | 41.89 | 1,195,764 | -434.34 | -99.85% |
| 5 Years | 435.00 | 503.25 | 0.4388 | 41.89 | 1,195,764 | -434.34 | -99.85% |
